Back

Racial and Ethnic Differences in Pregnancy Associated Overdose Mortality in the United States, 2016 to 2022

Cooper, H. L.; Peterson, E. N.; Kramer, M. R.

2026-03-17 addiction medicine
10.64898/2026.03.15.26348438 medRxiv
Show abstract

Pregnant and postpartum people who use drugs in the United States are trying to survive at the intersection of two of the gravest public health crises of the 21st century US: epidemics of (1) maternal mortality and (2) the overdose epidemic. Although extensive evidence documents racial/ethnic disparities in each of these epidemics separately, comparatively little research has characterized racial/ethnic patterns in their collision, that is, in maternal overdose mortality. We analyzed individual-level mortality records from the National Vital Statistics System (NVSS) for 2016-2022 to describe racial/ethnic disparities in pregnancy-associated overdose deaths (PA-OD) and pregnancy-associated substance use disorder-related deaths (PA-SUD). Racial/ethnic-specific mortality rates were calculated per 100,000 live births with exact Poisson confidence intervals. Temporal trends were summarized using annual percent change (APC), and disparities were quantified using rate ratios and differences relative to non-Hispanic White individuals. Overdose-related maternal mortality increased substantially during the study period across multiple racial and ethnic groups. Rates increased nearly threefold among non-Hispanic White individuals and rose more steeply among non-Hispanic Black individuals, producing a Black-White disparity that emerged over time. Rates among Hispanic individuals remained lower but increased rapidly, while estimates among American Indian and Alaska Native individuals were often high but unstable because of small counts. Substance use disorder-related maternal mortality exhibited a pronounced surge during 2019-2021 across several racial and ethnic groups. These findings highlight rapidly evolving racial/ethnic patterns in maternal overdose mortality and underscore the need for targeted prevention and harm-reduction strategies to reduce overdose-related deaths during pregnancy and the postpartum period. FundingWe are grateful to the following NIH grants for supporting this research: U54HD113292 and R01DA059182.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
JAMA Network Open
127 papers in training set
Top 0.1%
18.8%
2
Drug and Alcohol Dependence
37 papers in training set
Top 0.1%
18.7%
3
International Journal of Drug Policy
11 papers in training set
Top 0.1%
17.6%
50% of probability mass above
4
Addiction
25 papers in training set
Top 0.1%
6.4%
5
PLOS ONE
4510 papers in training set
Top 34%
4.3%
6
Neuropsychopharmacology
134 papers in training set
Top 0.8%
4.0%
7
Journal of General Internal Medicine
20 papers in training set
Top 0.4%
2.1%
8
The Lancet Public Health
20 papers in training set
Top 0.2%
1.8%
9
Frontiers in Psychiatry
83 papers in training set
Top 2%
1.8%
10
Translational Psychiatry
219 papers in training set
Top 3%
1.7%
11
Addiction Neuroscience
17 papers in training set
Top 0.3%
1.3%
12
Journal of the American Heart Association
119 papers in training set
Top 3%
1.3%
13
Alcoholism: Clinical and Experimental Research
13 papers in training set
Top 0.2%
1.2%
14
American Journal of Psychiatry
20 papers in training set
Top 0.3%
1.0%
15
Biological Psychiatry Global Open Science
54 papers in training set
Top 1%
0.8%
16
American Journal of Epidemiology
57 papers in training set
Top 1%
0.8%
17
JAMA Psychiatry
13 papers in training set
Top 0.5%
0.8%
18
British Journal of Pharmacology
34 papers in training set
Top 0.6%
0.7%
19
Pharmacology Research & Perspectives
11 papers in training set
Top 0.3%
0.7%
20
Addiction Biology
47 papers in training set
Top 0.7%
0.7%
21
The British Journal of Psychiatry
21 papers in training set
Top 0.9%
0.7%
22
JAMIA Open
37 papers in training set
Top 1%
0.7%
23
Nicotine and Tobacco Research
13 papers in training set
Top 0.2%
0.7%
24
PLOS Medicine
98 papers in training set
Top 5%
0.7%
25
Pharmacoepidemiology and Drug Safety
13 papers in training set
Top 0.5%
0.7%
26
Scientific Reports
3102 papers in training set
Top 80%
0.5%